Amy Roskin MD, JD

Chief Medical Officer at Seven Starling

Amy Roskin MD, JD is a medical professional with a breadth of experience in the healthcare industry. In 2022, they began their role as Chief Medical Officer for Seven Starling, a digital platform making high-quality mental healthcare more accessible for new mothers and caregivers. From 2021 to present, they have served as a Member of the Women Business Leaders of the US Health Care Industry Foundation (WBL). In 2020, they began their role as Medical Advisor, Chief Medical Officer, and Head of Clinical Operations and Medical Director for Favor (formerly The Pill Club). In 2019, they began their roles as Faculty for Florida International University - Herbert Wertheim College of Medicine, Medical Executive & Medical Director for INNOVO by Atlantic Therapeutics, and Telemedicine Physician for Maven Clinic. From 2016 to 2019, they served as Affiliate Assistant Professor for Florida Atlantic University, Charles E. Schmidt College of Medicine, and Adjunct Professor Of Law for Nova Southeastern University Shepard Broad College of Law. In 2018, they joined the Editorial Board of the Journal of Legal Medicine.

Amy Roskin MD, JD has a comprehensive educational background. Amy obtained a Bachelor's Degree from Princeton University, followed by a Doctor of Medicine (M.D.) from New York University. Amy completed a residency in Obstetrics & Gynecology at New York-Presbyterian Hospital through Columbia University. Lastly, they obtained a Juris Doctor (J.D.) from Nova Southeastern University Shepard Broad College of Law. Additionally, they are Board Certified in Obstetrics & Gynecology through the American Board of Obstetrics and Gynecology (ABOG) and is a Member of the Florida Bar through the Florida Board of Bar Examiners.

Links

Previous companies

Florida Atlantic University logo
Atlantic Therapeutics logo

Timeline

  • Chief Medical Officer

    June, 2022 - present

View in org chart